Status:
UNKNOWN
Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing.
Lead Sponsor:
Capital and Coast District Health board
Collaborating Sponsors:
Wellington Southern Community Laboratories
Institute of Environmental Science and Research
Conditions:
Bacterial Infections
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is a laboratory evaluation of a new testing methodology for microbiological diagnosis, whereby participant samples received as part of routine care will be divided between the standard diagnostic...
Detailed Description
Diagnostic microbiology has traditionally involved culture of organisms to diagnose infection, which is time consuming, insensitive for organisms that are difficult to grow, and compromised by prior a...
Eligibility Criteria
Inclusion
- All samples received by the WSCL microbiology laboratory for testing for the purposes of diagnosing infection will be eligible.
Exclusion
- Use of residual sample for mNGS testing may leave too little remaining sample and compromise standard diagnostic testing.
- Patients who have requested that their residual samples be returned to them.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04864873
Start Date
May 1 2021
End Date
May 1 2022
Last Update
August 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wellington Southern Community Laboratories
Wellington, New Zealand, 6021